Q32 Bio (QTTB) Return on Equity [ROE] (2018 - 2026)
Q32 Bio (QTTB) reported Return on Equity [ROE] of 44.02% for Q2 2026, down 31.00 percentage points from the prior quarter.
Powered by 
Analysis
Q32 Bio (QTTB) Return on Equity [ROE] (2018 - 2026) Analysis & Trends
For FY2025, Q32 Bio posted Return on Equity [ROE] of 125.06%.
- Return on Equity [ROE] has a five-year change of +181.70 percentage points (FY2020 to FY2025).
- By year, Return on Equity [ROE] came in at 2.48% in FY2022 (+54.86 pp) and -52.38% in FY2021 (+4.25 pp).
- The Q2 2026 figure ranks as the lowest quarterly Return on Equity [ROE] since Q1 2025.
- Over the past five years, the year-over-year gain in Return on Equity [ROE] ranged from 18.27 percentage points (Q4 2021) to 7100.18 percentage points (Q1 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 25.32% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 7.21% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 84.40% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 21.39% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 83.75% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -18.38% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 4.97% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 22.24% |
| 10 | Q32 Bio | 196.30 Mn | -77.99 Mn | - | 44.02% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 44.02% |
| Mar 31, 2026 | 75.02% |
| Dec 31, 2025 | 253.08% |
| Mar 31, 2025 | -7,025.17% |
| Dec 31, 2024 | -384.71% |
| Sep 30, 2024 | -228.22% |
| Jun 30, 2024 | -134.72% |
| Dec 31, 2022 | -3.79% |
| Sep 30, 2022 | -0.22% |
| Jun 30, 2022 | 0.21% |
| Mar 31, 2022 | -0.93% |
| Dec 31, 2021 | -52.01% |
| Sep 30, 2021 | -43.47% |
| Jun 30, 2021 | -42.12% |
| Mar 31, 2021 | -47.60% |
| Dec 31, 2020 | -70.28% |
| Sep 30, 2020 | -67.45% |
| Jun 30, 2020 | -59.09% |
| Mar 31, 2020 | -47.58% |
| Dec 31, 2019 | -40.25% |
API Access
Q32 Bio Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=QTTB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "QTTB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=QTTB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();